ACADIA Pharmaceuticals (ACAD) Insider Trading & Ownership → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free ACAD Stock Alerts $14.79 -0.06 (-0.40%) (As of 05/17/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media ACADIA Pharmaceuticals (NASDAQ:ACAD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage27.50%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$5.31 MNumber OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$8.35 M Get ACAD Insider Trade Alerts Want to know when executives and insiders are buying or selling ACADIA Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ACAD Insider Buying and Selling by Quarter Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. ACADIA Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/2/2024Brendan TeehanCOOSell3,477$16.94$58,900.38 5/2/2024James KiharaInsiderSell1,326$16.94$22,462.44 5/2/2024Mark C SchneyerCFOSell3,503$16.94$59,340.82 5/2/2024Stephen DavisCEOSell11,427$16.94$193,573.38 4/8/2024Brendan TeehanCOOSell2,568$17.87$45,890.16 4/8/2024James KiharaInsiderSell1,790$17.87$31,987.30 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/8/2024Mark C SchneyerCFOSell2,716$17.87$48,534.92 4/8/2024Stephen DavisCEOSell26,574$17.87$474,877.38 3/27/2024Brendan TeehanCOOSell5,140$17.90$92,006.00 3/27/2024Mark C SchneyerCFOSell5,434$17.90$97,268.60 3/27/2024Stephen DavisCEOSell17,714$17.90$317,080.60 2/26/2024Brendan TeehanCOOSell624$24.67$15,394.08 2/26/2024James KiharaInsiderSell474$24.67$11,693.58 2/26/2024Mark C SchneyerCFOSell772$24.67$19,045.24 2/26/2024Stephen DavisCEOSell5,577$24.67$137,584.59 1/8/2024Austin D KimEVPSell590$29.96$17,676.40 1/8/2024Brendan TeehanCOOSell731$29.96$21,900.76 1/8/2024Stephen DavisCEOSell3,732$29.96$111,810.72 12/15/2023James KiharaInsiderSell2,000$28.30$56,600.00 11/20/2023Brendan TeehanCOOSell4,960$22.64$112,294.40 11/20/2023James KiharaInsiderSell1,985$22.64$44,940.40 11/20/2023Mark C SchneyerCFOSell5,108$22.64$115,645.12 10/6/2023Austin D KimEVPSell16,369$21.96$359,463.24 10/6/2023Stephen DavisCEOSell51,563$21.96$1,132,323.48 9/15/2023James KiharaInsiderSell2,000$25.88$51,760.00 8/21/2023Mark C SchneyerCFOSell10,000$29.00$290,000.00 7/14/2023Stephen DavisCEOSell100,000$30.04$3,004,000.00 7/11/2023Stephen DavisCEOSell16,498$25.00$412,450.00 6/15/2023James KiharaInsiderSell2,000$24.15$48,300.00 6/12/2023Laura BregeDirectorSell4,500$24.87$111,915.00 6/8/2023Mark C SchneyerCFOSell974$25.02$24,369.48 5/23/2023Bros. Advisors Lp BakerDirectorBuy209,053$25.41$5,312,036.73 5/17/2023Brendan TeehanCOOSell14,869$22.50$334,552.50 5/17/2023James KiharaInsiderSell5,947$22.50$133,807.50 5/17/2023Mark C SchneyerCFOSell15,310$22.50$344,475.00 (Data available from 1/1/2013 forward) ACAD Insider Trading Activity - Frequently Asked Questions Who is on ACADIA Pharmaceuticals's Insider Roster? The list of insiders at ACADIA Pharmaceuticals includes Austin D Kim, Brendan Teehan, Bros. Advisors Lp Baker, James Kihara, Laura Brege, Mark C Schneyer, Srdjan R Stankovic, and Stephen Davis. Learn more on insiders at ACAD. What percentage of ACADIA Pharmaceuticals stock is owned by insiders? 27.50% of ACADIA Pharmaceuticals stock is owned by insiders. Learn more on ACAD's insider holdings. Which ACADIA Pharmaceuticals insiders have been buying company stock? The following insider purchased ACAD shares in the last 24 months: Bros. Advisors Lp Baker ($5,312,036.73). How much insider buying is happening at ACADIA Pharmaceuticals? Insiders have purchased a total of 209,053 ACAD shares in the last 24 months for a total of $5,312,036.73 bought. Which ACADIA Pharmaceuticals insiders have been selling company stock? The following insiders have sold ACAD shares in the last 24 months: Austin D Kim ($448,172.57), Brendan Teehan ($742,113.82), James Kihara ($430,341.60), Laura Brege ($340,040.00), Mark C Schneyer ($1,056,005.03), Srdjan R Stankovic ($48,798.35), and Stephen Davis ($6,288,408.89). How much insider selling is happening at ACADIA Pharmaceuticals? Insiders have sold a total of 402,649 ACADIA Pharmaceuticals shares in the last 24 months for a total of $9,353,880.26 sold. More Insider Trading Tools from MarketBeat Related Companies: Merus Insider Trades MoonLake Immunotherapeutics Insider Trades Bausch Health Companies Insider Trades TG Therapeutics Insider Trades Amicus Therapeutics Insider Trades Arrowhead Pharmaceuticals Insider Trades Corcept Therapeutics Insider Trades Janux Therapeutics Insider Trades IDEAYA Biosciences Insider Trades Vera Therapeutics Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:ACAD) was last updated on 5/18/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceThe Presidential candidate you should REALLY be worried aboutStansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressWhat’s Really Next for America…Porter & CompanyHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ACADIA Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.